Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| THCA | rs112224666 | chr1:152910501 | G/A | 0.000139 | 500 | 31.43 | 34.43 | 37.7 | KM Plot |
| THCA | rs112224955 | chr10:104926876 | G/A | 9.35E-14 | 500 | 31.43 | 35.08 | 32.1 | KM Plot |
| THCA | rs112240253 | chr10:104753726 | C/T | 8.96E-14 | 502 | 31.37 | 35.6 | 32.1 | KM Plot |
| THCA | rs112255065 | chr10:104665888 | C/T | 3.19E-9 | 501 | 31.03 | 34.18 | 29.58 | KM Plot |
| THCA | rs112317325 | chr8:58045962 | C/G | 4.28E-6 | 500 | 31.33 | 37.83 | 36.93 | KM Plot |
| THCA | rs112376039 | chr18:13821321 | C/CATGG | 1.27E-5 | 501 | 31.42 | 33.4 | 50 | KM Plot |
| THCA | rs112425217 | chr10:104778756 | G/A | 6.98E-14 | 503 | 31.15 | 36.02 | 32.1 | KM Plot |
| THCA | rs112472626 | chr2:29036679 | A/G | 0.000138 | 502 | 31.68 | 30.97 | 38.87 | KM Plot |
| THCA | rs112507051 | chr10:104648466 | C/T | 8.83E-14 | 501 | 31.37 | 36.17 | 32.1 | KM Plot |
| THCA | rs112679565 | chr14:24661174 | C/T | 6.38E-7 | 492 | 31.7 | 31.77 | 18.15 | KM Plot |
| THCA | rs112809537 | chr10:104670346 | C/T | 8.77E-14 | 501 | 31.03 | 35.87 | 32.1 | KM Plot |
| THCA | rs112831038 | chr10:131961468 | C/A | 1.18E-5 | 502 | 31.47 | 32.9 | 27.18 | KM Plot |
| THCA | rs112883152 | chr4:1081755 | C/T | 5.65E-5 | 489 | 31.47 | 31.47 | 36.43 | KM Plot |
| THCA | rs112955336 | chr12:14451380 | T/C | 5.34E-5 | 498 | 31.4 | 36.93 | 32.45 | KM Plot |
| THCA | rs113030473 | chr10:81649031 | G/T | 2.61E-9 | 494 | 31.7 | 31.45 | 14.52 | KM Plot |